🔗 Visit the ClinicalTrials.gov page for NCT02990416
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. | Blood | 2009 | 6.17 |
| 2 | Neoantigens in cancer immunotherapy. | Science | 2015 | 5.16 |
| 3 | Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment. | PLoS One | 2015 | 0.79 |